Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
Submitted by
admin
on May 12, 2017 - 9:40am
Source:
Endpoints
News Tags:
AstraZeneca
clinical trials
durvalumab
Imfinzi
non-small cell lung cancer
Headline:
AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
Do Not Allow Advertisers to Use My Personal information
